{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:40:57Z","timestamp":1791283257362,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Early identification of patients living with cancer at higher risk of death from an infection is critical in infection mortality prevention. We characterize patients living with cancer at the highest risk of dying from an infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>7,529,481 US cancer survivors (1992 to 2015) were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Standardized mortality ratios (SMRs) and 95% CIs were calculated. Fine-gray survival analysis was performed to calculate hazard ratios by adjusting for the effects of competing risks (eg, deaths due to causes other than infection).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 7,529,481 patients living with cancer (1992 to 2015), 101,167 (1.3%) died of infection. The rate of infection-specific mortality was 27.19\/10,000 person-years, with an SMR of 3.29 (95% CI: 3.26-3.32,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001). Patients who were older, male, black, and unmarried were at a greater risk of fatal infection. Overall, the risk of infection-specific mortality for patients living with cancer is greatest 1 year after diagnosis compared with the general population (SMR: 8.68, 95% CI: 8.53-8.84;\n                      <jats:italic toggle=\"yes\">P&lt;<\/jats:italic>\n                      0.0001), and this risk decreases with follow-up time (SMR at &gt;10\u00a0y after diagnosis: 2.93, 95% CI: 2.87-3.00;\n                      <jats:italic toggle=\"yes\">P&lt;<\/jats:italic>\n                      0.0001). Among patients with Hodgkin Lymphoma, Non-Hodgkin Lymphoma, and Kaposi Sarcoma, 9.2%, 11.5%, and 82.2% of all deaths within the first year after cancer diagnosis occurred due to acute infectious disease. In contrast, for patients with liver cancer, the relative percentage of infection-specific mortality increases with follow-up time from 3.5% at &lt;1 year after cancer diagnosis and 10.4% at 10+ years of follow-up.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The results of this study characterize infection mortality in patients living with cancer, which can guide more targeted research and interventions in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/coc.0000000000001182","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T21:51:24Z","timestamp":1743717084000},"page":"327-335","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Death From Infection Among Patients Living With Cancer"],"prefix":"10.1097","volume":"48","author":[{"given":"Mckenzee","family":"Chiam","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Penn State Cancer Institute"},{"name":"Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve School of Medicine, Cleveland, OH"},{"name":"Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8847-4726","authenticated-orcid":false,"given":"Kyle","family":"Mani","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, The Bronx"},{"name":"Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve School of Medicine, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[{"name":"Microsoft Corporation, Redmond, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Trifiletti","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie J.","family":"Parent","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Microbiology and Immunology, Division of Infectious Diseases and Epidemiology, Penn State College of Medicine, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Spratt","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve School of Medicine, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Tchelebi","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas G.","family":"Zaorsky","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve School of Medicine, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"R1-20250624","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R2-20250624","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1002\/cncr.25332","article-title":"Risk of mortality in patients with cancer who experience febrile neutropenia","volume":"116","author":"Lyman","year":"2010","journal-title":"Cancer"},{"key":"R3-20250624","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R4-20250624","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/cncr.21203","article-title":"Epidemiology and outcomes of serious influenza-related infections in the cancer population","volume":"104","author":"Cooksley","year":"2005","journal-title":"Cancer"},{"key":"R6-20250624","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.6004\/jnccn.2012.0146","article-title":"Prevention and treatment of cancer-related infections clinical practice guidelines in oncology","volume":"10","author":"Baden","year":"2012","journal-title":"J Natnl Comprehens Network"},{"key":"R9-20250624","doi-asserted-by":"crossref","first-page":"IV-3","DOI":"10.1097\/00005650-200208001-00002","article-title":"Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"key":"R10-20250624","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.currproblcancer.2012.03.007","article-title":"Overview of the Surveillance, Epidemiology, and End Results database: evolution, data variables, and quality assurance","volume":"36","author":"Park","year":"2012","journal-title":"Curr Probl Cancer"},{"key":"R12-20250624","first-page":"5","article-title":"Ambiguities in calculating cancer patient survival: the SEER experience for colorectal and prostate cancer","volume":"5","author":"Boer","year":"2002","journal-title":"Statist Res Applicat Branch NCI, Technical Report"},{"key":"R13-20250624","first-page":"1","article-title":"Statistical methods in cancer research. Volume II\u2013the design and analysis of cohort studies","volume":"82","author":"Breslow","year":"1987","journal-title":"IARC Sci Publ"},{"key":"R14-20250624","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.aje.a114083","article-title":"Another shortcut method for calculating the confidence interval of a Poisson variable (or of a standardized mortality ratio)","volume":"122","author":"Ury","year":"1985","journal-title":"Am J Epidemiol"},{"key":"R15-20250624","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2015.04.021","article-title":"Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006\u20132010","volume":"63","author":"Allison","year":"2015","journal-title":"J Hepatol"},{"key":"R16-20250624","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/QAD.0b013e328317cc2d","article-title":"Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study","volume":"23","author":"Crum-Cianflone","year":"2009","journal-title":"AIDS"},{"key":"R17-20250624","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/annonc\/mdw604","article-title":"Causes of death among cancer patients","volume":"28","author":"Zaorsky","year":"2017","journal-title":"Ann Oncol"},{"key":"R18-20250624","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1080\/1042819031000119262","article-title":"Risk of febrile neutropenia-among patients with intermediate-grade non-Hodgkin\u2019s lymphoma receiving CHOP chemotherapy","volume":"44","author":"Lyman","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"R19-20250624","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/21505594.2016.1208866","article-title":"Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection","volume":"7","author":"Mehta","year":"2016","journal-title":"Virulence"},{"key":"R20-20250624","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1200\/JCO.2016.68.8457","article-title":"Morbidity and mortality differences between hematopoietic cell transplantation survivors and other cancer survivors","volume":"35","author":"Chow","year":"2017","journal-title":"J Clin Oncol"},{"key":"R21-20250624","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"key":"R22-20250624","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1188\/10.CJON.81-86","article-title":"Managing neutropenia in older patients with cancer receiving chemotherapy in a community setting.","volume":"14","author":"I.","year":"2010","journal-title":"Clin J Oncol Nurs"},{"key":"R23-20250624","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00134-019-05853-1","article-title":"The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study","volume":"46","author":"Guidet","year":"2020","journal-title":"Intensive Care Med"},{"key":"R24-20250624","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2174\/18715206113136660346","article-title":"The complexity of aging: cancer risk among elderly people and infectious risk among those with cancer.","volume":"13","author":"Pinzone","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"R25-20250624","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1210\/en.2011-2120","article-title":"Immune cells have sex and so should journal articles","volume":"153","author":"Klein","year":"2012","journal-title":"Endocrinology"},{"key":"R26-20250624","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1210\/en.2011-2120","article-title":"Immune cells have sex and so should journal articles.","volume":"153","author":"Sabra L.","year":"2012","journal-title":"Endocrinology"},{"key":"R27-20250624","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/gene.2009.12","article-title":"Stronger inflammatory\/cytotoxic T-cell response in women identified by microarray analysis.","volume":"10","author":"Hewagama","year":"2009","journal-title":"Genes Immun"},{"key":"R28-20250624","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines.","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R29-20250624","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","article-title":"Sexual dimorphism of humoral immunity with human vaccines.","volume":"26","author":"Ian Francis","year":"2008","journal-title":"Vaccine"},{"key":"R30-20250624","first-page":"198","article-title":"The influence of sex and gender on immunity, infection and vaccination","volume":"52","author":"Ruggieri","year":"2016","journal-title":"Ann Ist Super Sanita"},{"key":"R31-20250624","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4062\/biomolther.2018.103","article-title":"Sex differences in cancer: epidemiology, genetics and therapy.","volume":"26","year":"2018","journal-title":"Biomol Ther"},{"key":"R32-20250624","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archsurg.134.9.935","article-title":"Male gender is a risk factor for major infections after surgery.","volume":"134","author":"Offner","year":"1999","journal-title":"Arch Surg"},{"key":"R33-20250624","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1158\/1055-9965.EPI-11-0246","article-title":"Sex disparities in cancer mortality and survival.","volume":"20","author":"Cook","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R34-20250624","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1097\/IGC.0000000000001068","article-title":"Single marital status and infectious mortality in women with cervical cancer in the United States.","volume":"27","author":"Machida","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R35-20250624","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1470-2045(03)01218-X","article-title":"Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment","volume":"4","author":"Vento","year":"2003","journal-title":"Lancet Oncol"},{"key":"R36-20250624","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-319-04220-6_2","article-title":"Epidemiology of infections in cancer patients.","volume":"161","author":"Zembower","year":"2014","journal-title":"Cancer Treat Res"},{"key":"R37-20250624","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3121\/cmr.2015.1276","article-title":"Principles and pitfalls: a guide to death certification","volume":"13","author":"Brooks","year":"2015","journal-title":"Clin Med Res"},{"key":"R38-20250624","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3109\/07357901003630959","article-title":"Should cause of death from the death certificate be used to examine cancer-specific survival a study of patients with distant stage disease","volume":"28","author":"Lund","year":"2010","journal-title":"Cancer Invest"},{"key":"R39-20250624","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/cncr.27968","article-title":"Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival","volume":"119","author":"Hu","year":"2013","journal-title":"Cancer"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0000000000001182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:53:30Z","timestamp":1786035210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/COC.0000000000001182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000001182","relation":{},"ISSN":["0277-3732","1537-453X"],"issn-type":[{"value":"0277-3732","type":"print"},{"value":"1537-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]}}}